Latest filing published 28 Dec 2015 for Oramed Pharmaceuticals INC., €1.0M.
Insider track record
No signal scores available.
Closed purchases
Based on 6 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -37.6%Entry US$11.05 · Close at T+365 US$6.90
- -41.5%Entry US$11.17 · Close at T+365 US$6.54
- -70.1%Entry US$15.97 · Close at T+365 US$4.77
- +30.7%Entry US$6.85 · Close at T+365 US$8.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Regals Capital Management LP: trading record in brief
Filings by Regals Capital Management LP span 2 companies, the busiest being Oramed Pharmaceuticals Inc. and Legend International Holdings Inc. We count 13 filings; the first trade dates from 25 June 2012 and the latest from 23 December 2015.
On the market, this insider has only ever bought: 10 purchases, €6.0M in total. No amount is published for 1 filing, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant.
In size, the median ticket on the buying side is €296k. After 6 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -19.2%. These figures describe past trades and do not predict future prices.
On 28 December 2015 came the latest disclosure, a share grant for €1.0M in Oramed Pharmaceuticals Inc. The clock since the last published purchase (10 June 2014) now reads 4,534 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Regals Capital Management LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 290,459 shares@ US$3.77Common StockSEC:0001140361-15-045731:0
- 2,252 shares@ US$4.44Common StockSEC:0001140361-14-024984:0Canonical exit: 4 Sept 2014 (T+90)
- 27,700 shares@ US$10.1537Common StockSEC:0001140361-14-014133:0Canonical exit: 22 Jun 2014 (T+90)
- 47,300 shares@ US$10.8996Common StockSEC:0001140361-14-014133:1Canonical exit: 23 Jun 2014 (T+90)
- 24,492 shares@ US$16.3236Common StockSEC:0001140361-14-005083:0Canonical exit: 6 May 2014 (T+90)
- 26,800 shares@ US$14.9605Common StockSEC:0001140361-14-005083:1Canonical exit: 7 May 2014 (T+90)
- 447 shares@ US$6.40Common StockSEC:0001140361-13-028008:0
- 103 shares@ US$6.4491Common StockSEC:0001140361-13-028008:1
- 6,630 shares@ US$7.3958Common StockSEC:0001140361-13-028008:2Canonical exit: 8 Oct 2013 (T+90)
- 45,000,000 shares@ US$0.05Common StockSEC:0001140361-13-008606:0Canonical exit: 20 May 2013 (T+90)
- 405,405 sharesCommon StockSEC:0001140361-12-045904:0Canonical exit: 31 Jan 2013 (T+90)
- 23,431,180 shares@ US$0.07Common StockSEC:0001140361-12-035793:0Canonical exit: 5 Nov 2012 (T+90)
- 22,640,725 shares@ US$0.10Common StockSEC:0001140361-12-031344:0Canonical exit: 23 Sept 2012 (T+90)
13 of 13 declarations
